ArticleFrontiers in oncology2026
Trends in breast cancer mortality and analysis of years of life lost among Chinese residents, 2013-2021.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to analyze breast cancer mortality trends and quantify the burden of premature death among Chinese residents from 2013 to 2021 to inform national prevention strategies and resource allocation. Methods: Data were obtained from the Chinese Cause of Death Monitoring Dataset. Joinpoint regression models were employed to calculate the Annual Percentage Change (APC) and Average Annual Percentage Change (AAPC) to characterize temporal trends. Furthermore, the study utilized Potential Years of Life Lost (PYLL), Average Years of Life Lost (AYLL), and the Value of Years of Life Lost (VYLL) to evaluate the impact of premature mortality on public health and the economy. Results: From 2013 to 2021, the national age-standardized mortality rate initially rose and then declined, resulting in no statistically significant net change over the study period (AAPC = -0.03, 95% Conclusions: While national breast cancer mortality rates have stabilized, the burden is shifting toward rural regions. The persistence of high premature mortality in resource-limited areas highlights an urgent need for equitable resource allocation and targeted early screening programs to address these widening regional health disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.